Navigation Links
Two New Alzheimer's Disease Studies Show Advances Against Different Treatment Targets
Date:7/28/2008

the individual cognitive tests as a function of both treatment and length of treatment.

High dose AL-108 gave a statistically significant improvement in the delayed match-to-sample test (DMTS 12s). After four weeks, a 34.2 percent change from baseline (p=0.067, versus placebo) was seen; by Week 16, a 62.4 percent improvement from baseline was observed (p=0.038, versus placebo), showing a durable response four weeks after treatment ended.

An improvement on the digit span forward test of the high dose group became statistically significant at Week 8, with an 11.2 percent change from baseline (p=0.032, versus placebo), and remained significant at Week 16 with an 11.7 percent change from baseline (p=0.052, versus placebo).

The low dose AL-108 was not different from placebo. AL-108 was well tolerated with similar rates of adverse events (AEs) in placebo and AL-108 treated subjects. The most common AE was headache which occurred at a rate expected in this patient population. No serious AEs were associated with AL-108.

"Twelve weeks of AL-108 treatment given intranasally by spray resulted in a statistically significant, dose-dependent and durable improvement on measures of short-term memory, including visual, verbal, and auditory working memory, which is a type of memory function that deteriorates throughout the progression of Alzheimer's," Schmechel said.

"This makes AL-108 the first drug to validate in humans the importance of the 'tangle' or 'tau' pathway in Alzheimer's. Based on these results in MCI, there are plans for further development of AL-108 in Alzheimer's," Schmechel added.

Insulin and Diabetes Drugs May Reduce Alzheimer's Brain Lesions

Several large-scale studies have shown that people with diabetes have a higher risk of developing Alzheimer's than persons without diabetes. At the same time, previous research showed that some people with diabetes had fewer Alzheimer's-associated brain lesions than non-diabetic
'/>"/>

SOURCE Alzheimer's Association
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Medivation Announces Publication in The Lancet of Dimebon Pivotal Trial Results in Alzheimers Disease
2. Michael J. Fox Foundation Awards $2.4 Million for Validation of Nine Promising Therapeutic Targets for Parkinsons Disease
3. Raptor Pharmaceuticals Enters Collaboration Agreement with UC San Diego in Liver Disease
4. Bapineuzumab To Become the First-to-Market Disease-Modifying Alzheimers Drug After Flurizans Discontinuation
5. Snapshots of Eyes Could Serve as Early Warning of Diabetes or Diabetic Eye Disease, U-M Researchers Report
6. Medivation Announces Positive Top-Line Results From Phase 2 Dimebon Study in Huntingtons Disease
7. Medivation to Host Conference Call at 5 p.m. EDT Monday to Discuss Top-Line Phase 2 Study Results in Huntingtons Disease
8. Current Concepts in Clostridium difficile Infection: A Focus on Recurrent Disease
9. Micromet and Nycomed Begin Formal Preclinical Safety Studies for Antibody MT203 for Inflammatory and Autoimmune Diseases
10. Pivotal Pulmonary Arterial Hypertension Study Published in The Lancet Concludes That Bosentan (Tracleer(R)) Demonstrates Benefits in Patients With Mildly Symptomatic WHO Functional Class II Disease
11. U.S. FDA Approves Requip(R) XL(TM), the First and Only Oral Once-Daily Non-Ergot Dopamine Agonist for Parkinsons Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... HILL, N.C. , Feb. 27, 2015 ... over the past decade but one thing hasn,t changed: ... MSLs to build relationships with Key Opinion Leaders. ... recognized as the most valuable type of interaction, field ... limits on their KOL interactions. This is just one ...
(Date:2/27/2015)... , Feb. 27, 2015  Following a ... Committee that moved H.R. 284, the Medicare DMEPOS ... American Association for Homecare (AAHomecare) released a statement ... action to pass the legislation. "Today,s ... the House Ways and Means Committee is a ...
(Date:2/27/2015)... An aggressive campaign to reduce the unnecessary ... infection with a dangerous drug-resistant bacteria at The Valley ... or C.diff, is a bacterium that can cause symptoms ... A recent article in the New England Journal of ... the United States " asserts that "C. ...
Breaking Medicine Technology:Improving the Management of MSL Teams to Create Value across a Diverse Set of Customers 2Bidding Fix Takes Major Step Forward After Bipartisan Vote of House Ways and Means Committee 2Curb Overuse Of Antibiotics To Reduce Drug-Resistant Superbug 2Curb Overuse Of Antibiotics To Reduce Drug-Resistant Superbug 3
... Globulin Study Uncovers Sample,Manipulation, Design Flaws, NIXA, ... analysis,released today critically examined a recent industry-sponsored,study ... Rh immune globulin,(RhIg) injections, some of which ... flaws, the,analysis uncovered manipulation of the study ...
... and SUNNYVALE, Calif., June 27, 2007,/PRNewswire-FirstCall/ -- ... open-label, multi-center Phase 2,clinical trials supporting the ... company's lead product,candidate, in combination with Alimta(R) ... a second-line treatment,for patients with non-small cell ...
Cached Medicine Technology:Genetics Journal Thimerosal/Autism Study the 'Best Science Drug,Company Money Can Buy' 2Genetics Journal Thimerosal/Autism Study the 'Best Science Drug,Company Money Can Buy' 3Pharmacyclics Announces Interim Results From Two Ongoing Phase 2,Trials Supporting Potential of Xcytrin Plus Chemotherapy to Treat,Recurrent Non-Small Cell Lung Cancer 2Pharmacyclics Announces Interim Results From Two Ongoing Phase 2,Trials Supporting Potential of Xcytrin Plus Chemotherapy to Treat,Recurrent Non-Small Cell Lung Cancer 3Pharmacyclics Announces Interim Results From Two Ongoing Phase 2,Trials Supporting Potential of Xcytrin Plus Chemotherapy to Treat,Recurrent Non-Small Cell Lung Cancer 4Pharmacyclics Announces Interim Results From Two Ongoing Phase 2,Trials Supporting Potential of Xcytrin Plus Chemotherapy to Treat,Recurrent Non-Small Cell Lung Cancer 5
(Date:3/1/2015)... (PRWEB) March 01, 2015 “ The Barrel ... monthly Tech Report, which takes a look at the latest ... Tropeano, the host of NewsWatch and a technology expert, conducted ... spiral adds flavor to drinks. , According to Home Distillation ... the best spirits. Well, there’s a pretty cool product that’ll ...
(Date:2/28/2015)... 2015 The MCA Youth Empowerment Conference ... one platform and gears towards the goal for a ... of group talks in smaller groups will be held ... Personal Development, Leadership, Entrepreneurship, Healthcare, Social and Volunteerism, Women ... Malaysian youths. , Young adults aged between ...
(Date:2/28/2015)... In a recent episode of SCI TV ... Athlete Development Services and Consultancy talks with Joshua ... development and player engagement during and after their careers. ... face and how off-field activities are a critical component ... in athlete development issues while in graduate school coaching ...
(Date:2/28/2015)... The Heart Fit Clinic started doing ... the machine. The Heart Fit Clinic is also selling ... franchise model. The goal is to scale the business ... To buy External Counterpulsation machines can be ... through this process and achieve the desired results. ...
(Date:2/28/2015)... 28, 2015 Mew and Company, a ... they now provide business consulting services in addition to ... tax planning and succession planning. Company finances are a ... professionals. On top of this, complex Canadian tax laws ... accounting. As a result, Mew and Company works to ...
Breaking Medicine News(10 mins):Health News:An Oak Infusion Spiral was Featured on NewsWatch Television on January 30, 2015 2Health News:My Mobile University Appointed Learning Partner for the Upcoming MCA’S First Youth Empowerment Conference Held in Malaysia on March 28, 2015 2Health News:My Mobile University Appointed Learning Partner for the Upcoming MCA’S First Youth Empowerment Conference Held in Malaysia on March 28, 2015 3Health News:My Mobile University Appointed Learning Partner for the Upcoming MCA’S First Youth Empowerment Conference Held in Malaysia on March 28, 2015 4Health News:SCI TV Covers Athlete Development with Duncan Fletcher 2Health News:SCI TV Covers Athlete Development with Duncan Fletcher 3Health News:Clinicians Can Now Purchase External Counterpulsation with Heart Fit Clinic 2Health News:Vancouver Corporate Tax Accountants Now Provide Business Consulting Services 2
... According to an inquest heard, a patient was given a lethal ... than 100 hours in a week.// ,Dr Helen Pike, ... her. The patient, Tony Wright, 58 suffered a massive cardiac arrest ... in the hospital’s ICU. ,Once his wife heard about ...
... for a new study has shown that even few pounds overweight ... compared// to those who maintain the optimum weight. ... was conducted involving 500,000 people, which took into consideration their lifestyle ... , ,The study revealed that obese people carried ...
... costs as well as indirect costs for employers, ... Occupational and Environmental// Medicine, official publication of the ... ,Led by Dr. Gene Colice of ... a large insurance database to analyze costs associated ...
... a spurt in cases of diarrhea, nausea, and vomiting, which ... outbreak. ,A common infection at this time ... to have taken a virulent form. It would do good ... infection. It is important to wash hands well after the ...
... has found a way to reduce brain swelling, the most ... doctoral student Renée Turner in the Discipline of Pathology at ... brain seems to mimic a similar process in the skin, ... these are yet to be developed. ,“This potentially ...
... American and South African scientists working at the epicenter ... how the human immunodeficiency virus// (HIV) “exhausts” killer T ... found that HIV can simply “turn off” fully functional ... cells. In test tube studies, however, the scientists showed ...
Cached Medicine News:Health News:Sheer exhaustion makes a junior doc’ kill a patient! 2Health News:Sheer exhaustion makes a junior doc’ kill a patient! 3Health News:Insurance Data Show High Costs of Persistent Asthma 2Health News:How HIV "Exhausts" Killer T Cells 2Health News:How HIV "Exhausts" Killer T Cells 3Health News:How HIV "Exhausts" Killer T Cells 4
Laryngectomy Tubes with special J-shape for convenient placement through a tracheostomy stoma....
SPIRAL-FLEX® Reinforced Oral/Nasal Uncuffed Endotracheal Tubes...
SPIRAL-FLEX® Reinforced Oral/Nasal Cuffed Endotracheal Tubes...
Pre-Loaded with a Stylet., ,Available Cuffed or Uncuffed, pre-loaded with a stylet to facilitate quick intubations....
Medicine Products: